Eagle Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $665K | Buy |
|
|||||
|
2024
Q2 | $449K | Buy |
|
|||||
|
2024
Q1 | $370K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $171K | Buy |
|
|||||
|
2021
Q2 | $157K | Buy |
|
|||||
|
2021
Q1 | $172K | Buy |
|
|||||
|
2020
Q4 | $56K | Sell |
|
|||||
|
2020
Q3 | $143K | Sell |
|
|||||
|
2020
Q2 | $203K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $170K | Sell |
|
|||||
|
2019
Q1 | $305K | Buy |
|
|||||
|
2018
Q4 | $278K | Buy |
|
|||||
|
2018
Q3 | $342K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $290K | Sell |
|
|||||
|
2016
Q2 | $329K | Buy |
|
|||||
|
2016
Q1 | $311K | Buy |
|
|||||
|
2015
Q4 | $307K | Buy |
|
|||||
|
2015
Q3 | $223K | Buy |
|
|||||
|
2015
Q2 | $223K | Buy |
|